Orthopedic surgery

Completion of First in Human Clinical Trial Two-Year Follow-up for the LIFT Implant

Retrieved on: 
Tuesday, November 7, 2023
Ageing, Visual analogue scale, Orthopedic surgery, Clinical trial, Patella, Osteoarthritis, Knee, Safety, Pain, European, Patient, Arthritis, Medical device

KENTFIELD, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- ZKR Orthopedics, Inc. a clinical stage medical device company, today announced successful completion of two-year follow up on subjects enrolled in the first-in-human clinical trial.

Key Points: 
  • KENTFIELD, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- ZKR Orthopedics, Inc. a clinical stage medical device company, today announced successful completion of two-year follow up on subjects enrolled in the first-in-human clinical trial.
  • The 18-patient trial conducted in the European Union was designed to evaluate the safety of the LIFT implant technology on patients with varying stages of patellofemoral cartilage degeneration.
  • Further, the trial collected data related to pain, function, and radiographic imaging to evaluate the performance of the LIFT implant as a surgical alternative.
  • The trial will evaluate the performance of the LIFT implant technology compared to tibial tubercle osteotomy in patients aged 25-65 with cartilage degeneration and osteoarthritis of the patellofemoral compartment of the knee.

Keiretsu Forum’s Investor Capital Expo Highlights Resilience and Opportunity in Early-Stage Investments

Retrieved on: 
Monday, October 30, 2023
Humanetics, Health, Infection, Keiretsu Forum, Orion, Pediatrics, Kidney failure, Abuse, Weissmann, Gq alpha subunit, Research, Dialysis, Orthopedic surgery, Biotechnology, Angel Capital Association, Drug discovery, VC, Ligament, Tendon, Cancer, AI, Investment, Therapy, Defense, Patient, Automation, DART, Peritoneal dialysis, Fire, Capital, Tourism, Pharmaceutical industry, Q1

Despite this backdrop, the 11th Annual Investor Capital Expo in Philadelphia on October 25, 2023, drew the participation of 200 forward-thinking accredited angel investors attending in person and virtually.

Key Points: 
  • Despite this backdrop, the 11th Annual Investor Capital Expo in Philadelphia on October 25, 2023, drew the participation of 200 forward-thinking accredited angel investors attending in person and virtually.
  • Keynote, Ron Weissman , Chair of the Angel Capital Association counselled participants that short-term demand for capital exceeds supply but, that this market correction is not a collapse.
  • Keiretsu Forum Mid-Atlantic and South-East is coming off of three consecutive years of record breaking angel member investments.
  • For more information on upcoming investor meetings and company presentations, contact Keiretsu Forum Mid-Atlantic and South-East at [email protected]

BellaSeno Presents Novel Production Workflow for Customized, 3D-Printed Bone Scaffolds

Retrieved on: 
Monday, October 30, 2023
FDM, Medical device regulation, Medtech, MDR, Bone, Injury, CT, Workflow, Orthopedic surgery, ISO, Sterilization, 3D printing, Medical device, Traumatology

The presentation titled "Semi-automated workflow for the design and fabrication of 3D-printed patient-specific resorbable scaffolds for the treatment of large segmental bone defects while complying with MDR regulations" outlined the potential of BellaSeno´s novel resorbable scaffolds for curing large segmental bone defects (> 5cm size).

Key Points: 
  • The presentation titled "Semi-automated workflow for the design and fabrication of 3D-printed patient-specific resorbable scaffolds for the treatment of large segmental bone defects while complying with MDR regulations" outlined the potential of BellaSeno´s novel resorbable scaffolds for curing large segmental bone defects (> 5cm size).
  • The scaffold is needed to hold the autologous bone graft in position for optimal vascularization and bone healing.
  • Scaffolds made by additive manufacturing from bioresorbable polymers represents a highly attractive opportunity to produce such patient-specific open-pore scaffolds.
  • This results in a new generation of high-performance bone scaffolds which are well suited for the biological reconstruction of large bone defects."

Rising Orthopedic Clinics and Innovative Products Propel US Casting Tapes & Pads Market with a 7.2% CAGR - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 2, 2023
Medical Supplies, Health, Female, Ascending limb of loop of Henle, Injury, Orthopedic surgery, Organization, Growth, Hospital, Patient satisfaction, Elective surgery, Patient, Breathability, Compound annual growth rate, Nursing, Dyeing

The US casting tapes & pads market is on a trajectory of substantial growth, with a projected Compound Annual Growth Rate (CAGR) of 7.2% from 2022 to 2028.

Key Points: 
  • The US casting tapes & pads market is on a trajectory of substantial growth, with a projected Compound Annual Growth Rate (CAGR) of 7.2% from 2022 to 2028.
  • This market analysis report provides comprehensive insights into the industry, highlighting the shift towards advanced products like breathable casting tapes and waterproof paddings.
  • The US casting tapes & pads market is experiencing significant growth, driven by the following key highlights:
    Orthopedic Clinics Expansion: With over 29,000 orthopedic clinics in the US, their numbers are increasing alongside the growing target population.
  • Polyester Synthetic Pads: Polyester synthetic casting pads, designed for patient comfort, find popularity among patients with sensitivities or wounds.

Health Plus Management (HPM)-Supported Practice South Island Orthopedics (SIO) Expands Physical Therapy Services into Cedarhurst, NY

Retrieved on: 
Monday, November 6, 2023
HPM, Partner (business rank), Physician, Central Avenue, MD, Health, Quality of life, Orthopedic surgery, Growth, SIO, Patient, Nursing

NEW YORK, Nov. 6, 2023 /PRNewswire/ -- Health Plus Management (HPM) is thrilled to announce the expansion of its supported practice, South Island Orthopedics (SIO), with the introduction of a state-of-the-art physical therapy center in Cedarhurst, NY.

Key Points: 
  • NEW YORK, Nov. 6, 2023 /PRNewswire/ -- Health Plus Management (HPM) is thrilled to announce the expansion of its supported practice, South Island Orthopedics (SIO), with the introduction of a state-of-the-art physical therapy center in Cedarhurst, NY.
  • Strategically positioned at 610 Central Avenue, Cedarhurst, NY, this facility sits just down the block from SIO's existing orthopedics practice at 657 Central Avenue.
  • Health Plus Management and South Island Orthopedics share a unified commitment to providing a best-in-class patient experience while expanding services and the practice's reach within the region and beyond.
  • With Health Plus Management's unwavering support, South Island Orthopedics can focus on their core strengths, ensuring exceptional clinical outcomes.

American Joint Replacement Registry Releases 10th Annual Report

Retrieved on: 
Friday, November 3, 2023
American Joint Replacement Registry, MSTR, III, Publication, Medicare, American Association of Neurological Surgeons, Nursing, Abdominal ultrasonography, Registry, Fracture, Orthopedic surgery, Paced Auditory Serial Addition Test, Estate (law), KOOS, ASR, TKA, Hip, Growth, Database, SER, COVID-19, Surgeon, AANS, American Academy, Hospital, Annual report, Collection, THA, Shoulder, Patient, Robotics, AAOS, FTR, Medical device, Pharmaceutical industry, BBC, MD

ROSEMONT, Ill., Nov. 3, 2023 /PRNewswire/ -- The American Joint Replacement Registry (AJRR), the cornerstone of the American Academy of Orthopaedic Surgeons (AAOS) Registry Program, published its 2023 Annual Report on hip and knee arthroplasty procedural trends and patient outcomes today. Marking the 10th anniversary edition of the report, the data represents over 3.1 million primary and revision hip and knee arthroplasty procedures performed between 2012 and 2022. This is a 23% growth in procedural cases from the prior report.

Key Points: 
  • ROSEMONT, Ill., Nov. 3, 2023 /PRNewswire/ -- The American Joint Replacement Registry (AJRR), the cornerstone of the American Academy of Orthopaedic Surgeons (AAOS) Registry Program , published its 2023 Annual Report on hip and knee arthroplasty procedural trends and patient outcomes today.
  • Marking the 10th anniversary edition of the report, the data represents over 3.1 million primary and revision hip and knee arthroplasty procedures performed between 2012 and 2022.
  • The American Joint Replacement Registry (AJRR) , the Academy's hip and knee replacement registry, is the cornerstone of the AAOS's Registry Program, and the world's largest national registry of hip and knee joint replacement data by annual procedural count, with more than 3 million procedures contained within its database.
  • Additional registries include the Fracture & Trauma Registry (FTR), the Musculoskeletal Tumor Registry (MsTR), the Shoulder & Elbow Registry (SER), and the American Spine Registry (ASR), a collaborative effort between the American Association of Neurological Surgeons (AANS) and the AAOS.

POLARIS[AR] RECEIVES CLEARANCE FROM THE U.S. FOOD AND DRUG ADMINISTRATION FOR STELLAR KNEE

Retrieved on: 
Friday, November 3, 2023
Knee, FDA, Standard of care, Columbia University Irving Medical Center, Food, Surgeon, Orthopedic surgery, Elective surgery, University of California, Regulation of tobacco by the U.S. Food and Drug Administration, Software, Environment, Mixed reality, University, Columbia University, Algorithm, Augmented reality, Robotics, Associate, Medical device, Medical imaging

MIAMI, Nov. 3, 2023 /PRNewswire/ -- POLARISAR is pleased to announce today that their STELLAR Knee has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

Key Points: 
  • MIAMI, Nov. 3, 2023 /PRNewswire/ -- POLARISAR is pleased to announce today that their STELLAR Knee has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
  • STELLAR Knee is the first clearance for POLARISAR, a company focused on creating a new category in Mixed Reality surgical guidance.
  • The STELLAR Knee workflow is open and available to be utilized across all total knee replacement implant systems.
  • STELLAR Knee not only impacts the surgeon and the patient, but also empowers healthcare providers to change the standard of care."

American Physical Therapy Association Announces New Editor-In-Chief of PTJ: Physical Therapy & Rehabilitation Journal

Retrieved on: 
Wednesday, November 1, 2023
Duke University School of Medicine, Duke University, Health, MPA, Department of Defense Instruction 1300.28, Doctor of Philosophy, Research, American Physical Therapy Association, Rehabilitation, Growth, Student, Therapy, PT, Bangladesh Technical Education Board, APTA, Oxford University Press, Pharmaceutical industry, Nursing, Orthopedic surgery, PTJ

ALEXANDRIA, Va., Nov. 1, 2023 /PRNewswire/ -- The American Physical Therapy Association announces the appointment of Steven Z. George, PT, PhD, FAPTA, as editor-in-chief of its flagship scientific journal, PTJ: Physical Therapy & Rehabilitation Journal.

Key Points: 
  • ALEXANDRIA, Va., Nov. 1, 2023 /PRNewswire/ -- The American Physical Therapy Association announces the appointment of Steven Z. George, PT, PhD, FAPTA, as editor-in-chief of its flagship scientific journal, PTJ: Physical Therapy & Rehabilitation Journal.
  • George and his collaborators have authored over 320 peer-reviewed publications in leading physical therapy, medical, orthopaedic, rehabilitation, and pain research journals.
  • His research has been funded by the National Institutes of Health, the Department of Defense, and the Academy of Orthopaedic Physical Therapy of the American Physical Therapy Association.
  • The American Physical Therapy Association represents more than 100,000 physical therapists, physical therapist assistants, and physical therapy students nationwide.

Integer Holdings Corporation Reports Third Quarter 2023 Results

Retrieved on: 
Thursday, October 26, 2023
Stroke, NYSE, EBITDA, GAAP, Acquisition, Cardio-Vascular, PMA, Intracranial aneurysm, Growth, Electrochemistry, EPS, Electrophysiology, CRM, Video game, Textile, Bank, Neuromodulation, Orthopedic surgery

PLANO, Texas, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results for the three months ended September 29, 2023.

Key Points: 
  • PLANO, Texas, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results for the three months ended September 29, 2023.
  • Third Quarter 2023 Highlights (compared to Third Quarter 2022, except as noted)
    Sales increased 18% to $405 million, with organic growth of 18%.
  • Integer’s fourth quarter 2023 outlook includes $5 million sales and $1 million adjusted operating income from InNeuroCo.
  • Electrochem sales decreased 25% in the third quarter 2023 compared to the third quarter 2022, returning to a normalized run-rate after previously higher sales from the supply chain recovery.

Aclarion Announces Signing of Commercial Agreement With Porter Hospital, an AdventHealth facility, to Bring Nociscan Technology to Denver

Retrieved on: 
Wednesday, October 25, 2023
Low back pain, MRI, Biomarker, AdventHealth, Physician, Environment, KOL, ACON, Orthopedic surgery, Algorithm, CO, Pain, Patient, Software as a service, Medical imaging, Nursing

BROOMFIELD, CO, Oct. 25, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today their expanded footprint in Colorado with AdventHealth Porter.  From their location in Denver, AdventHealth Porter provides exceptional medical care to patients throughout the front range of Colorado.

Key Points: 
  • From their location in Denver, AdventHealth Porter provides exceptional medical care to patients throughout the front range of Colorado.
  • At AdventHealth Porter, we are committed to provide the highest quality cost effective care possible.
  • Biomarker data is entered into proprietary algorithms to highlight if a disc may be a source of pain.
  • When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient’s low back pain, giving physicians clarity to optimize treatment strategies.